Aims: Faculty recruitment into leadership positions is increasingly more difficult. The purpose of this research study was to explore the perceived barriers and challenges to leadership positions in schools of allied health professions from a faculty perspective.
Methods: This study utilized an exploratory, survey design with convenience sampling. The survey was electronically disseminated to academic representatives within the 115 ASAHP member institutions. Survey questions included basic demographic and faculty information and addressed perceptions of barriers and challenges related to leadership positions.
Results: Responses were collected from 310 individuals, of whom 268 who completed the entire survey. Of these, 125 identified themselves as "full-time faculty within the institution and no prior administrative/leadership experience." Respondents were primarily female, white, non-Hispanic, with 10 or fewer years of faculty experience. The top five perceived barriers included: time demands, concerns about increased workload, lack of experience, family obligations, and lack of mentoring. The top five perceived challenges included: time management/workload demands, budgeting, faculty personnel issues, resource constraints, and fundraising.
Conclusion: Institutions should consider position announcements that reflect behaviors and characteristics versus rank and faculty line, provide education on daily responsibilities, and implement intentional mentoring and professional development in the area of leadership positions.
Download full-text PDF |
Source |
---|
Acad Emerg Med
January 2025
UnityPoint Health-Des Moines, Des Moines, Iowa, USA.
Introduction: The emergency physician (EP) workforce has been a recent focus after a workforce projection predicted a surplus of EPs by 2030. A previous study of Iowa emergency departments (EDs) demonstrated wide variability in ED staffing patterns and attributed it to the lack of EP job candidates. With the recent increase in emergency medicine (EM) residency positions, the objectives of this study were to understand how Iowa ED physician staffing has changed in regard to presence of board-certified EPs and what operational differences in Iowa EDs may be associated with staffing to provide insight into what may be occurring in other predominantly rural states.
View Article and Find Full Text PDFPatient Prefer Adherence
January 2025
Respiratory Research@Alfred, Monash University, Melbourne, VIC, Australia.
Purpose: Oral corticosteroids (OCS) are an effective treatment for severe uncontrolled asthma or asthma exacerbations, but frequent bursts or long-term use carry serious and sometimes irreversible adverse effects, or complications such as adrenal insufficiency upon discontinuation. Our aim was to survey people with asthma on their experiences of, and attitudes towards, using OCS.
Patients And Methods: This study was a national descriptive cross-sectional survey of people with asthma in Australia.
Isr J Health Policy Res
January 2025
School of Medicine, Faculty of Medical and Health Sciences and the Coller School of Management, Tel Aviv University, Tel Aviv, Israel.
Background: Israel is unique in offering a formal subspecialty in Medical Administration and mandating it for physicians applying for senior roles. Data on the prevalence and characteristics of these specialists are limited.
Methods: The national registry of licensed physicians was used to identify all living physicians who completed the Medical Administration subspecialty by December 31, 2022.
Surg Endosc
January 2025
Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Introduction: The SAGES Guidelines Committee creates evidence-based clinical practice guidelines (CPGs). Updates which incorporate new evidence into the guidelines are necessary to maintain relevance for clinical use. A description of our standard operating procedure for this process is described here, which contributes to SAGES' commitment to producing high-quality clinical recommendations.
View Article and Find Full Text PDFLancet
January 2025
Department of Diagnostic and Interventional Radiology, University of Pisa School of Medicine, Pisa, Italy.
Background: Transarterial chemoembolisation (TACE) is standard of care for patients with unresectable hepatocellular carcinoma that is amenable to embolisation; however, median progression-free survival is still approximately 7 months. We aimed to assess whether adding durvalumab, with or without bevacizumab, might improve progression-free survival.
Methods: In this multiregional, randomised, double-blind, placebo-controlled, phase 3 study (EMERALD-1), adults aged 18 years or older with unresectable hepatocellular carcinoma amenable to embolisation, an Eastern Cooperative Oncology Group performance status of 0 or 1 at enrolment, and at least one measurable intrahepatic lesion per modified Response Evaluation Criteria in Solid Tumours (RECIST) were enrolled at 157 medical sites including research centres and general and specialist hospitals in 18 countries.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!